Your browser doesn't support javascript.
loading
How many patients are eligible for disease-modifying treatment in Alzheimer's disease? A French national observational study over 5 years.
Epelbaum, Stéphane; Paquet, Claire; Hugon, Jacques; Dumurgier, Julien; Wallon, David; Hannequin, Didier; Jonveaux, Thérèse; Besozzi, Annick; Pouponneau, Stéphane; Hommet, Caroline; Blanc, Frederic; Berly, Laetitia; Julian, Adrien; Paccalin, Marc; Pasquier, Florence; Bellet, Julie; Boutoleau-Bretonniere, Claire; Charriau, Thiphaine; Rouaud, Olivier; Madec, Olivier; Mouton, Aurélie; David, Renaud; Bekadar, Samir; Fabre, Roxane; Liegey, Emmanuelle; Deberdt, Walter; Robert, Philippe; Dubois, Bruno.
Afiliação
  • Epelbaum S; Institute of Memoryand Alzheimer's Disease (IM2A) and Brain and Spine Institute(ICM) UMR S 1127, Inria, Aramis-Project Team, Department of Neurology, AP-HP, Pitié-Salpêtrière University Hospital, Sorbonne Universities, Pierre et Marie Curie University, Paris 06 and National Reference Center for Rare
  • Paquet C; Neurology Memory Center, Lariboisière FW Saint Louis University Hospital, Paris, France.
  • Hugon J; Center of Cognitive Neurology, Groupe hospitalier Lariboisiere Fernand-Widal, Paris, France.
  • Dumurgier J; Cognitive Neurology Center, CMRR Paris-Nord Ile-de-France, Groupe hospitalier Lariboisiere Fernand-Widal, Paris, France.
  • Wallon D; Cognitive Neurology Center, CMRR Paris-Nord Ile-de-France, Groupe hospitalier Lariboisiere Fernand-Widal, Paris, France.
  • Hannequin D; U942 Team Biomarkers and Neurocognition, INSERM/Université Paris Diderot, Paris, France.
  • Jonveaux T; Department of Neurology, Rouen University Hospital, Rouen, France.
  • Besozzi A; Department of Neurology, CHU Charles Nicolle, Rouen, France.
  • Pouponneau S; Gériatrie, CHRU de Nancy, Nancy, France.
  • Hommet C; Gériatrie, CHRU de Nancy, Nancy, France.
  • Blanc F; Gériatrie, CHU de Tours, Tours, France.
  • Berly L; Gériatrie, CHU de Tours, Tours, France.
  • Julian A; Department of Neurology, University Hospital of Strasbourg, Strasbourg, France.
  • Paccalin M; Gériatrie, CHU de Strasbourg, Strasbourg, France.
  • Pasquier F; Gériatrie, CHU de Poitiers, Poitiers, France.
  • Bellet J; Geriatrics Department University Hospital La Milétrie, Poitiers, France.
  • Boutoleau-Bretonniere C; Neurology, Centre Hospitalier Regional et Universitaire de Lille (CHRU- LILLE), Lille, France.
  • Charriau T; Neurology, Centre Hospitalier Regional Universitaire de Lille Pole Neurosciences et Appareil Locomoteur, Lille, France.
  • Rouaud O; CHU Nantes, Nantes, France.
  • Madec O; Neurology, CHU de Nantes, Nantes, France.
  • Mouton A; Neurology, CHU de Dijon, Dijon, France.
  • David R; Neurology, CHU de Dijon, Dijon, France.
  • Bekadar S; Department of Neuropsychiatry, CHU de nice, Nice, France.
  • Fabre R; Centre Mémoire de Ressources et de Recherche, Centre Hospitalier Universitaire de Nice, Nice, France.
  • Liegey E; Department of Clinical Research, Institut du cerveau et de la moelle epiniere, Paris, France.
  • Deberdt W; Department of Neuropsychiatry, CHU de nice, Nice, France.
  • Robert P; Délégation à la Recherche Clinique et à l'Innovation, Assistance publique-Hôpitaux de Paris, Paris, France.
  • Dubois B; Medical Department, Eli Lilly and Co, Indianapolis, Indiana, USA.
BMJ Open ; 9(6): e029663, 2019 06 24.
Article em En | MEDLINE | ID: mdl-31239309

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article